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Costimulatory moleculebe a necessary step in the generation of an effective immune response. We have
used vaccinia virus (VACV) as a model to investigate the regulation of DC subsets in vivo following infection.
While a number of in vitro studies have shown that DC infected with VACV fail to undergo maturation, the
effect of VACV infection on the maturation of and cytokine production by DC subsets in vivo remains less
deﬁned. We have found that following systemic infection with vaccinia virus, both CD8+ and CD8− dendritic
cells are infected. The number of infected DC peaked at 6h and was highly decreased by 24h post-infection. In
both subsets, there was evidence of generalized upregulation of costimulatory molecules. Surprisingly, this
included vaccinia infected DC, suggesting the regulation of DC maturation in vivo is much more complex
and likely inﬂuenced by DC extrinsic signals. However, while we observed generalized upregulation of
costimulatory molecules, IL-12 production was restricted to a subset of non-infected cells in both the CD8+
and CD8− DC populations. Importantly, the control of IL-12 production was differentially dependent on
MyD88 signaling. IL-12 production was ablated in the absence of MyD88 in CD8− DC, while it was unchanged
in CD8+ DC. These ﬁndings provide new insights into the control of DC maturation in vivo and demonstrate
that the regulation of maturation in vivo following virus infection can be differentially controlled in distinct
types of DC.
© 2008 Elsevier Inc. All rights reserved.IntroductionDendritic cells are a critical player in the activation of naive T cells.
Numerous studies support the view that maturation is required for DC
to become efﬁcient activators of T cells (for review see Macagno et al.,
2007). Maturation involves the upregulation of costimulatory mole-
cules, like CD80 and CD86, as well as the production of cytokines,
especially IL-12. Given the critical importance of DC maturation it is
perhaps not surprising that viruses have developed mechanisms to
inhibit this process. One example of such a virus is vaccinia virus
(VACV), which has a large arsenal of immune evasion proteins that
counteract many of the anti-viral mechanisms of the innate and
adaptive immune response (Alcami and Koszinowski, 2000; Seet et al.,
2003). The VACV proteins encoded by the K3L and E3L genes speciﬁcally
inhibit dsRNA resulting in a failure to produce and respond to type I IFN,
a potent cytokine for DC maturation (Beattie et al., 1991; Chang et al.,
1992; Paez and Esteban, 1984; Xiang et al., 2002). In addition, the
protein encoded by the A46R gene can block TLR signaling bynder-Miller).
ersity of Pittsburgh School of
l rights reserved.interacting with TLR adaptor proteins MyD88, Toll-IL-1 receptor
domain-containing adaptor-inducing IFN-beta (TRIF), and TRIF-related
adapter molecule (TRAM) (Stack et al., 2005), while the A52R gene
encodes a protein that has been implicated in blocking TLR signaling by
blocking activation of NF-κB, a key transcription factor involved in the
induction of inﬂammatory gene transcription (Bowie et al., 2000; Harte
et al., 2003; Sen and Baltimore, 1986b; Sen and Baltimore, 1986a;
Baeuerle and Henkel, 1994). Each of these proteins has the potential to
impact dendritic cell maturation and therefore to affect the ability of DC
to contribute to the generation of an adaptive immune response.
Based on the myriad of immunoregulatory proteins produced by
vaccinia virus, it was not surprising that our previous studies found
that in vitro infection of murine bone marrow derived dendritic cells
(BMDC) did not result in maturation (Yates and Alexander-Miller,
2007). A similar ﬁnding has been reported for human DC (Drillien et
al., 2000; Engelmayer et al., 1999). However the failure of vaccinia
virus infection to induce maturation was seemingly at odds with
the reports that direct presentation contributes signiﬁcantly to the
generation of a CD8+ T cell response in vivo (Basta et al., 2002; Shen et
al., 2002), a process which presumably would require a mature DC.
Not surprisingly, cross-presentation mediated by CD8+ DC, has also
been shown to contribute to the generation of a T cell response
following infection with VACV (Basta et al., 2002; Shen et al., 2002).
Fig.1. The percentage of eGFP+ cells peaks at 6 h post-infection in both CD8+ and CD8− subsets. C57BL/6 mice were intravenously infected with 1×107 pfu of VACV-NP-S-EGFP. At 6,15,
24 and 48 h p.i., splenic DC were enriched using CD11c magnetic beads. Cells were stained with antibodies to CD11c and CD8. (A) Representative FSC/SSC and CD11c vs. CD8 plots. (B)
Representative plots following gating on CD11c+ CD8− (top row) or CD11c+ CD8+ (bottom row) populations. (C) Average percent eGFP+ DC from 4 independent experiments. (D)
Average number of eGFP+ DC in the CD8+ or CD8− subsets over time.
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generation of an anti-viral response necessitates identiﬁcation of how
these populations respond following in vivo infection. For example,
are distinct subsets equally susceptible to infection and how does their
maturation state differ with regard to the expression of costimulatory
molecules and cytokines important for T cell activation? In the present
study, we addressed these issues using the model of systemic vaccinia
virus infection. We found that all DC exhibited increased expression of
the costimulatory markers CD80 and CD86. This included infected DC,
a result counter to that found with in vitro studies. However, in
contrast to the generalized upregulation of costimulatorymolecules in
infected as well as non-infected DC, IL-12 productionwas restricted to
non-infected cells. While IL-12 production was apparent in both CD8+
and CD8− DC populations, surprisingly the mechanism by which IL-12
production was controlled differed substantially between the subsets.
CD8− DC produced this cytokine in an MyD88 dependent manner
while CD8+ DC were independent of this signaling pathway. These
data suggest that while both subsets have the ability express the
signals necessary to directly activate naive CD8+ T cells, the me-
chanism by which they achieve the requisite maturation state is
distinctly controlled.
Results
Both CD8+ and CD8− dendritic cells in the spleen are infected following
intravenous administration of vaccinia virus
In a previous study, CD8+ dendritic cells were reported to be the
relevant subset for the activation of naive CD8+ T cells following
infection with vaccinia virus (Belz et al., 2004). This ﬁnding suggested
that CD8− DC either lacked viral antigen or the appropriate cos-
timulatory molecules necessary for T cell activation. To test this ﬁrst
possibility, we employed a recombinant vaccinia virus that expressed
a fusion protein wherein the Ova 257–264 epitope had been inserted
between the inﬂuenza NP protein and eGFP (VACV-NP-S-EGFP)
(Norbury et al., 2002). Following intravenous administration of virus,
we determined the extent to which CD8+ and CD8− DC were infected
as measured by the expression of eGFP. At 6, 15, 24 or 48h post-
infection, splenic DC were isolated by enrichment with CD11c mag-Fig. 2. EGFP+ CD8+ and CD8− DC show evidence of direct infection. C57BL/6 mice were intrave
using CD11c magnetic beads. Cells were stained with antibodies to CD11c and CD8. Nuclei a
direct infection. Representative eGFP+ CD8+ and eGFP+ CD8− DC are shown.netic beads. Isolated cells were stained with antibodies to CD11c and
CD8 and analyzed by ﬂow cytometry for the presence of eGFP. These
studies showed that both CD8+ and CD8− DC were susceptible to
infection and for both subsets, infection was maximal at 6h (Fig. 1). At
this time, on average approximately 1.7% of CD8− DC and 1.8% of CD8+
DC were eGFP+. The percentage of positive cells decreased signiﬁcantly
by 15h, with very limited to undetectable numbers by 48h post-
infection, depending on the animal examined. The changes in the
absolute number of eGFP+ cells mirrored the percentages, peaking at
6h and declining in a time-dependent fashion thereafter (Fig. 1D).
To determine whether eGFP positivity was a readout for infected
cells, we performed microscopic analysis to determine the
localization of the eGFP protein. The VACV-NP-S-EGFP construct
expresses eGFP as part of a chimeric protein wherein the SIINFEKL
epitope and eGFP are appended to the C terminus of the NP protein.
Thus virally-expressed eGFP localizes to the nucleus as a result of
the karyophilic properties of NP (Norbury et al., 2002). As such,
nuclear localization of eGFP can be used as an indicator of viral
synthesis in the cell. Analysis of eGFP expression in infected
dendritic cells isolated at 6h p.i. showed nuclear localization in both
DC subsets, consistent with infection (Fig. 2). There was no evi-
dence of punctate cytoplasmic staining that would be expected if
cells were eGFP+ as a result of uptake of exogenous eGFP. Together
these data show that both CD8+ and CD8− DC were susceptible to
infection with a transient early wave of infected dendritic cells that
is highly diminished by 24–48 p.i.
Dendritic cells infected with vaccinia virus upregulate CD80 and CD86
It has been recently reported that DC in the spleen of vaccinia
virus infected cells exhibit generalized upregulation of CD86 (Zhu
et al., 2007). However, given the small percentage of cells that
were infected our analysis (Fig. 1), it was feasible that infected
cells failed to upregulate CD86 and that this was not evident in the
analysis of the overall population. Thus the question of whether
DC infected in vivo underwent maturation remained unknown. To
address this issue, CD11c+ cells were isolated from mice at 6, 15,
24, and 48h post-infection with VACV-NP-S-EGFP. As a measure of
maturation, expression of CD80 and CD86 on eGFP+ CD11c+ cellsnously infected with 1×107 pfu of VACV-NP-S-EGFP. At 6 h p.i., splenic DC were enriched
re visualized by DAPI staining. Co-localization of DAPI staining and eGFP is indicative of
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infected cells failed to undergo maturation (Yates and Alexander-
Miller, 2007), the expression of CD80 and CD86 was signiﬁcantly
increased on eGFP+ DC isolated from infected mice compared to
DC obtained from mock-infected mice (Fig. 3). This was not the
result of virus-isolate speciﬁc differences as this construct failed to
induce DC maturation in vitro (data not shown), a ﬁnding in agree-
ment with our previous studies using the VV-Ova virus (Yates
and Alexander-Miller, 2007). Costimulatory molecule expression
increased over the 24h that infected cells were routinely de-
tectable following infection. On average CD8−dendritic cells ex-
hibited a 3.0-fold increase in CD80 expression and a 15.7-fold
increase in CD86 expression, while CD8+ DC increased CD80 ex-
pression by 5.7-fold and CD86 expression by 9.2-fold over the ﬁrst
24h of infection (Fig. 3A right two columns and 3B, gray bars).
Thus DC infected in vivo efﬁciently upregulate the expression of
costimulatory molecules.
We compared the level of expression of CD80 and CD86 on the
eGFP− cells to that on eGFP+ cells to determine whether these two
populations exhibited similar upregulation of these molecules. Non-
infected cells, both CD8+ and CD8− populations, showed similar
increases in CD80 and CD86 expression compared to eGFP+ cells (Fig.
3). On average CD8− dendritic cells exhibited a 3.1-fold increase in
CD80 expression and an 10.6-fold increase in CD86 expression, while
CD8+ DC increased CD80 expression by 4.5-fold and CD86 expression
by 7.4-fold over the ﬁrst 24h of infection (Fig. 3A, left two columns
and 3B, black bars). This bystander maturation suggested the pre-
sence of a signal that can induce generalized upregulation of cos-
timulatory molecules. This effect was restricted to early times post-
infection as DC present in the spleen at 48h showed little evidence of
maturation.
A subpopulation of eGFP− DC produce IL-12p40
The upregulation of maturation markers on the majority of cells
suggested that many of the dendritic cells present in the spleen,
including infected cells, had the potential to deliver costimulatory
signals for T cell activation. However, optimal CD8+ T cell activation
requires a cytokine signal, IL-12 or IFNαβ (Curtsinger et al., 2003;
Hernandez et al., 2002; Curtsinger et al., 2005). In this regard, IL-12
has been shown to be critical for the generation of lytic function in
vaccinia-speciﬁc effectors (van den Broek et al., 2000). As a recent
study has reported that the requirements for the production of IL-12
differ from those required for the upregulation of costimulatory
molecules (Schulz et al., 2000), we tested whether cells that had
upregulated costimulatory molecules also produced IL-12. At 6 or 24h
p.i., splenocyte populations isolated following collagenase digestion
were cultured overnight in the presence of GolgiPlug to promote
cytokine accumulation. The presence of IL-12p40 was then deter-
mined by ICCS. These analyses showed that while upregulation of
costimulatory molecules was relatively promiscuous, IL-12 production
was restricted to a small subset of cells in both the CD8+ and CD8−
populations (Fig. 4). Further IL-12p40 producing cells were restricted
to the eGFP− populations (Fig. 4A). The production of IL-12 peaked
early and was reduced in DC isolated 24h p.i. These data suggested
that 1) a fraction of the DC in each subset was receiving an additional
signal that promoted IL-12 production and that 2) infected DC were
either resistant to or did not encounter this signal.
IL-12 production is differentially dependent onMyD88 in CD8+ versus CD8−DC
The production of IL-12 is often a consequence of TLR engagement.
TLR receptors, with the exception of TLR3, utilize MyD88 for signal
transduction (Akira et al., 2000). To determinewhether IL-12 production
following VACV infection was dependent on MyD88 we administered
virus to MyD88-deﬁcent mice or WT C57BL/6 mice. At 6h p.i. DC wereisolated and cultured overnight in the presence of GolgiPlug as above. In
agreement with our hypothesis, there was a complete loss of IL-12
production in the absence of MyD88 in CD8− DC, with the percentage of
IL-12p40+ cells reduced to that found in mock-infected animals (Fig. 5).
However, in stark contrast to the results obtained for CD8− DC, the
production of IL-12p40 by CD8+ DC was similar in DC obtained fromWT
and MyD88-deﬁcient mice. These data suggest that IL-12 production is
differentially controlled in the CD8+ versus CD8− DC subsets.
Both CD8+ and CD8− DC are capable of activating naive T cells
The upregulation of costimulatory molecules on both infected
CD8+ and CD8− DC and the presence of IL-12 producing DC within
these two populations suggested that both subsets would be
competent for activation of CD8+ T cells. To test this possibility mice
were intravenously infected with VACV-NP-S-EGFP and at 6 and 24h
post-infection, mice were euthanized and splenic DC isolated. CD11c+
CD8+ and CD11c+ CD8− DC were sorted and co-cultured with OT-I cells
from naive mice. On d3, cells were restimulated with Ova257–264
peptide and the production of IFNγ determined by intracellular
staining. The results in Fig. 6 demonstrate that both CD8+ and CD8− DC
were capable of activating OT-I T cells to become IFNγ-producing
effectors. At 6h post-infection the two subsets appeared similar in
their activating potential. However, by 24h p.i. CD8− DC were inferior
to CD8+ cells, showing a 45% reduction in the percentage of cells that
could produce IFNγ. Nonetheless, both CD8+ and CD8− DC have the
capacity to contribute to the generation of the CD8+ T cell response.
Transfer of naive CD8+ T cells at 48h post-infection results in a reduced
effector population compared to that obtained when cells are transferred
at earlier timepoints
A prediction of the analysis of costimulatory molecule expression
is that DC present at 48h would be reduced in their ability to activate
naive T cells, i.e. T cells that encounter DC at this time would be
predicted to be less efﬁciently activated. To test this possibility, OT-I
cells were transferred into CD8-deﬁcient mice infected with VACV-
NP-S-EGFP 6, 24, or 48h prior. Infection was staggered such that OT-I
cells were transferred simultaneously for all conditions, thus ensuring
an identical pool of responders (Fig. 7A). Analysis of IFNγ producing
cells revealed that the peak number of Ova257–264-speciﬁc effectors
was obtained when OT-1 cells were transferred at 24 h following
infection (Fig. 7B). Transfer of OT-I cells at 6 h post-infection resulted
in a somewhat reduced (40%) Ova257–264-speciﬁc CD8+ T cell po-
pulation. Although unknown at this time, a number of possibilities
could explain this result including initial encounter with a DC that
was incompletely matured or activation by infected DC at early times
versus cross-presenting DC at later times, which may differ in their
efﬁciency of activation. Importantly, when transfer of OT-I cells was
delayed until 48 h p.i., the number of IFNγ-producing cells decreased
by 4-fold compared to that observed at 24 h p.i. This was not due to
the failure of these cells to enter into the effector pool because of an
ongoing endogenous response, as the recipient mice were devoid of
CD8+ Tcells. These data strongly support our analysis of DCmaturation
markers and suggest that optimal priming of CD8+ T cells occurs
within the ﬁrst 24 h following infection.
Discussion
While there are now a relatively large number of reports assessing
the regulation of DCmaturation as a result of viral infection in vitro, in
vivo studies to address this question aremuchmore limited. The latter
are of importance as they allow analysis of DC subsets that may not be
adequately reproduced through in vitro differentiation cultures. Fur-
ther, and perhaps more signiﬁcantly, in vivo studies permit the con-
tribution of the complex vivo environment, including additional cell
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Fig. 4. IL-12 production is limited to a subpopulation of eGFP− DC. C57BL/6 mice were intravenously infected with 1 × 107 pfu of VACV-NP-S-EGFP. At 6 or 24 h p.i., splenocytes were
cultured overnight in the presence GolgiPlug. Following culture, cells were stained with CD11c and CD8-speciﬁc antibodies followed detection of IL-12 production by ICCS.
Representative data from 6 hr p.i. are shown in A and averaged data from 6 and 24 hr p.i. in B. ⁎p≤0.005.
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used in vitro. In our studies, we have used vaccinia virus as a model to
probe the regulation of DC subsets in vivo-focusing on CD8+ vs. CD8−
populations. This divisionwasbased onpreviousﬁndings suggesting the
critical role of CD8+ DC in the activation of naive virus-speciﬁc CD8+ T
cells (Belz et al., 2004).
Our data show that vaccinia virus infected DC undergo maturation
in vivo, as measured by the upregulation of CD80 and CD86. Further
the majority of these infected cells are not undergoing apoptosis (data
not shown). That said, it remains possible that some of the infected,
dying cells are quickly cleared in vivo and thus are not observed in our
analysis. Nonetheless, the presence of mature, infected DC in vivo is in
sharp contrast to what we and others have observed in vitro, where
bone marrow derived DC do not increase costimulatory marker ex-
pression following infection with vaccinia virus (Drillien et al., 2000;
Engelmayer et al., 1999; Yates and Alexander-Miller, 2007). One
possibility to explain themature phenotype of infected DC observed in
our study was that vaccinia virus infection targeted cells that were
already mature. However, our kinetic data argue against this in-
terpretation as CD80 and CD86 expression was only modestly up-
regulated at 6 h p.i. In addition infection of previously matured DC in
vitro was highly abortive, suggesting mature DC are resistant to in-
fection (Yates and Alexander-Miller, 2007).
We noted that the level of CD80 and CD86 expressed by infected
DC was similar to the generalized DC maturation observed in the
non-infected population. This would be consistent with a model of a
shared signal for the induction of CD80 and CD86 in infected versus
non-infected DC. In a previous report by Zhu et al., the authors
found that the increased costimulatory molecule expression follow-
ing infection with vaccinia virus was the result of a combination of
an MyD88-dependent TLR2 signal and an MyD88-independentFig. 3. EGFP+ and eGFP− DC undergo similar upregulation of CD80 and CD86. C57BL/6 mice w
splenic DC were enriched using CD11c magnetic beads. Cells were stained with antibodies to
eGFP+ and eGFP− cells following gating on CD11c+ CD8− and CD11c+ CD8+ populations. (B) Ave
cells. Results are shown as fold change over DC from mock-infected animals to allow compsignal (Zhu et al., 2007). Further the increase was independent of
type I IFN (Zhu et al., 2007). We have reproduced this latter ﬁnding
and in addition have determined that maturation is also indepen-
dent of TNFα (data not shown). However, it remains possible that
other soluble factors present in the infected environment induce
maturation.
Both DC subsets were competent for T cell activation as judged by
the acquisition of IFNγ producing capabilities in the responding Tcells.
Proliferation induced by CD8+ versus CD8− DC was relatively similar,
although the amount of proliferationwas somewhat variable between
experiments (data not shown). We note that these analyses were
complicated by higher than expected proliferation when DC from
mock-infected mice were utilized. Although very few cells were re-
covered under this condition, those that were present had undergone
high amounts of proliferation, however, importantly they did not
produce IFNγ. Thus acquisition of IFNγ producing capability appears
to be the more stringent readout of activation in this approach.
We did note that while CD8− and CD8+ DC isolated at 6 h p.i. were
similar in their activating potential, at 24 h p.i. CD8+ DC displayed an
increased capacity to induce effector function. This could be the result
of a number of factors, including the level of presented antigen or the
number of cells presenting antigen. For example, at later times p.i.,
presentation may be increased in CD8+ DC as a result of cross-
presentation, whereas in CD8− DC, presentation remains limited to the
small number of infected cells present at this time. The restriction of
IL-12 production, a factor shown inmany instances to be important for
effector cell function, to eGFP− DC would suggest that either IFNγ
production by effector T cells generated in the context of a vaccinia
virus infection does not require IL-12 or that non-infected DC supply
this factor in trans to T cells in conjugate with peptide-presenting
infected cells. Certainly it seems reasonable that T cells could utilizeere intravenously infected with 1×107 pfu of VACV-NP-S-EGFP. At 6, 15, 24 and 48 h p.i.,
CD11c, CD8, CD80, and CD86. (A) Representative CD80 and CD86 proﬁles over time for
rage increases in CD80 and CD86 expression in eGFP− (black bars) and eGFP+ (gray bars)
arison across the four experiments.
Fig. 5. CD8− and CD8+ DC differ in their dependence onMyD88 for the production of IL-12.
MyD88-deﬁcient C57BL/6 or WT C57BL/6 mice were infected intravenously with 1×107
pfu of VACV-NP-S-EGFP. Six hours p.i., splenocytes were isolated and cultured overnight in
the presence of GolgiPlug. Cells were then stainedwith CD11c and CD8-speciﬁc antibodies
followed detection of IL-12 production by ICCS. Data are from 6 animals run over three
experiments. ⁎p≤0.005.
Fig. 6. Both CD8+ and CD8− DC can activate naive T cells. Splenic DC were isolated from
C57BL/6 mice at 6 or 24 h p.i. with 1×107 pfu of VACV-NP-S-EGFP. Cells were stained
with CD11c and CD8-speciﬁc antibodies, followed by sorting into CD11c+ CD8− and
CD11c+ CD8+ populations. 2.5×104 OT-I cells and 1×105 DC were co-cultured for 3 days
after which cultures were restimulated with 1 μM Ova257–264 peptide and IFNγ
production determined by ICCS. The percentage of CD8+ T cells that produced IFNγ is
shown. Results are the average of 4–5 independent experiments. ⁎p≤0.05, ⁎⁎p≤0.005.
Fig. 7. Transfer of OT-I cells at 48 h p.i. results in reduced activation compared to transfer
at 6 or 24 h p.i. CD8-deﬁcient recipient mice were infected with VACV-NP-S-EGFP at 6,
24, or 48 h prior to transfer of OT-I splenocytes (1×105) (A). On d3 post-transfer,
splenocytes were isolated and IFNγ production determined by ICCS following
stimulation with Ova257–264 peptide. The total number of IFNγ producing cells from
each condition is shown (B). Data are the average of 5 mice/condition compiled from
two independent experiments.
148 R.D. Yammani et al. / Virology 378 (2008) 142–150this cytokine if produced by neighboring DC in close proximity. We
point out that in the case of CD8+ DC, non-infected, IL-12-producing
cells may be efﬁcient activators of CD8+ T cells as a result of cross-
presentation of viral antigen, although this remains untested at this
time.
An attractive possibility for the increased activating potential of
CD8+ DC at later times is that it is the result of the increased CD80
expression on CD8+ vs. CD8− DC. CD80 increased by 3-fold in eGFP+
CD8− DC compared to 5.7-fold in eGFP+ CD8+ DC. CD80 expression in
eGFP− DC was also increased to a higher level in CD8+ vs. CD8− DC. We
have recently reported the important and non-redundant role played
by CD80 versus CD86 in the activation of CD8+ T cells (Pejawar-Gaddy
and Alexander-Miller, 2006). CD80 is critical for the maximal
upregulation of CD25 expression following activation of naive CD8+
T cells. Thus the higher levels of CD80 expressed by CD8+ DC may
contribute to increased proliferation and acquisition of effector
function. Another possibility is that it is a result of the higher per-
centage of CD8+ DC which produce IL-12, a factor known to be in-
volved in the acquisition of effector function (Curtsinger et al., 2003).
These models are not mutually exclusive and it is possible that
multiple factors contribute to the increased efﬁcacy of CD8+ DC.
The ability of both CD8+ and CD8− DC to serve as APC for the
activation of naive T cells was surprising to us given the previous
report from Belz and co-workers showing that only CD8+ DC were
capable of activating T cells. One potential difference to explain this
discrepancy is the lower dose of virus used in their study. Given that
the analysis was performed at 24 h, a timepoint where a large per-
centage of infected cells has been lost (Fig. 1 and Belz et al., 2004), it is
possible that the number of infected CD8− DC was not at sufﬁcient
levels to be detected in the assay. The timepoint at which DC aremaximally contributing to T cell activation in our model appears to
occur within 24 h p.i. In agreement, a recent report from Hickman et
al. suggested that the majority of priming following subcutaneous
administration of VACV occurred within 12 h following infection
(Hickman et al., 2008). Thus DC presenting antigen at the early times
may be the most relevant for CD8+ T cell activation.
The ﬁnding that both CD8− and CD8+ populations were infected by
vaccinia virus and undergo maturation supports the previously re-
ported role of direct and cross-presentation in the generation of the
anti-viral response in vivo (Basta et al., 2002; Shen et al., 2002). Our
understanding of these subsets would suggest that CD8+ DC may
contribute through both direct and cross-priming, while CD8− DC are
149R.D. Yammani et al. / Virology 378 (2008) 142–150restricted to the direct presentationpathway. The use of bothpathways
of presentation for Tcell activation is likely advantageous as a previous
report has suggested that direct infection results in the presentation of
VACV-derived epitopes that are not generated by cross-presentation
(Basta et al., 2002). Thus direct presentation of viral antigens may
promote a more comprehensive immune response, ensuring that
major epitopes that are presented as a result of infection can be
recognized by the T cell response. The development by the immune
system of multiple approaches for T cell activation ensures efﬁcient
presentation and T cell activation in the face of poxvirus infection.
The restriction of IL-12 production to a subset of uninfected DCwas
unexpected. This ﬁnding suggested that IL-12 production was not
triggered by infection, at least not infection that proceeded to the level
of detectable eGFP expression. Previous studies have indicated that
in some cases the production of IL-12 requires conditioning by a
microbial signal followed by a T cell derived CD40 L signal (Schulz et
al., 2000). Thus it was possible that CD40 engagement on a small
subset of DC was responsible for IL-12 production we observed.
However, infection of CD40-deﬁcient mice with vaccinia virus did not
result in the loss of IL-12 production (data not shown). Given the
commonly observed role of TLR signaling in the control of IL-12
production (Bekeredjian-Ding et al., 2006), we tested whether the
production of IL-12 was dependent on signaling through MyD88, an
adapter molecule involved in all TLR signaling except TLR3 (Akira et
al., 2000). Surprisingly we found that the requirement for signaling
throughMyD88 differed in the CD8+ versus CD8− subset, with CD8+ DC
production of IL-12 being independent of this pathway. Importantly,
these data suggest that the two DC subsets respond to infection via
distinct mechanisms. While the signals responsible for IL-12 produc-
tion in CD8+ vs. CD8− DC are unknown, one possibility is differential
TLR receptor expression in the two DC types. CD8+ DC and CD8− DC
have been reported to diverge in their expression of TLR receptors
(Edwards et al., 2003). CD8+ DC lack expression of TLR7, but have 28-
fold higher expression of TLR3 (Edwards et al., 2003). Given that TLR3
signal transduction is mediated through TRIF, this receptor may
promote MyD88-independent signals that result in IL-12 production.
In support of the ability of VACV to utilize this pathway, peritoneal
macrophages frommice with a defective TRIF protein were decreased
in their ability to limit vaccinia replication (Hoebe et al., 2003). Studies
are underway to address whether VACV signals through distinct TLR
receptors in these two DC populations. Alternatively, it is possible that
cytoplasmic receptors, e.g. RIG-I or DAI (Takaoka et al., 2007; Onomoto
et al., 2007), are differentially expressed or regulated in these cells. DAI
is a recently reported sensor of cytoplasmic DNA (Takaoka et al., 2007),
while RIG-I recognizes dsRNA (Onomoto et al., 2007). However, the
role of these receptors in the innate response to VACV infection has
not been investigated.
In conclusion, the studies presented here provide a model for the
regulation of CD8+ and CD8− DC in vivo following infectionwith VACV.
We ﬁnd that both subsets supported synthesis of viral protein
following infection and expressed high levels of costimulatory mole-
cules. Although IL-12 was not produced by these cells, IL-12 producing
DC that could serve as a source of signal 3 were found within both the
CD8+ and CD8− populations. Surprisingly the mechanism by which
IL-12 production was controlled differed between CD8+ and CD8− DC
populations. To our knowledge this is the ﬁrst report of differential
control of cytokine production in these two populations following
viral infection in vivo and suggests diverse types of DC are sensing
viral infection in distinct ways. In the larger picture these data sug-
gest that in vivo targeting of distinct DC subsets for maturation and
cytokine production may require independent strategies, i.e. trigger-
ing of different TLR or cytoplasmic sensors. Finally, on a practical
level, our studies suggest caution in applying in vitro ﬁndings with
regard to DC regulation to the in vivo setting. This does not necessarily
mean that the nature of the interaction between the virus and DC
differs in vivo, although it may, but certainly that signals fromneighboring cells are likely to have a profound effect on the control of
DC maturation.
Materials and methods
Mice and infections
C57BL/6 mice were purchased from the Frederick Cancer Research
and Development Center (Frederick, MD). OT-I/RAG-1 (004175) mice
were obtained through the NIAID Exchange Program, NIH: (Hogquist
et al., 1994; Mombaerts et al., 1992). CD8-deﬁcient mice on a C57BL/6
background (B6.129 S2-cd8 atm1Mak/J) (Fung-Leung et al., 1991) were
purchased from Jackson Laboratories (Bar Harbor, ME). The MyD88-
deﬁcient mice (on a C57BL/6 background) were provided by Dr Jason
Hoth (Wake Forest University School of Medicine) with permission
from Dr Shizuo Akira (Kawai et al., 1999). The recombinant vaccinia
virus VACV-NP-S-EGFP was a kind gift from Jack Bennink (NIH)
(Princiotta et al., 2003). VACV was sucrose gradient puriﬁed prior to
infection of mice. Mice were infected intravenously with 1×107 pfu of
VACV. All research performed on mice in this study complied with
federal and institutional guidelines set forth by the Wake Forest
University Animal Care and Use Committee.
Isolation of splenic DC
Minced spleens from C57BL/6micewere incubated in the presence
100 μg/ml Collagenase D (Roche, Indianapolis, IN) for 30 min at 37 °C.
The tissue was then passed through a 70 μm ﬁlter. CD11c+ cells were
enriched by positive selection using the Miltenyi microbeads as per
the manufacturer's instructions (Miltenyi Biotec, Auburn, CA).
Cell staining and ﬂow cytometry
DC were stained with the following antibodies: allophycocyanine-
conjugated anti-CD11c, phycoerythrin-conjugated anti-CD80, and
PerCpCy5.5 conjugated anti-CD8 (all from BD, San Diego, CA) and
Paciﬁc Blue conjugated anti-CD86 antibodies (BioLegend, San Diego,
CA). Flow cytometric analysis was performed using a FACSAria and
data analyzed with Diva software (both from BD, San Diego, CA).
Fluorescent microscopy
Cells were isolated from the spleens of mock or infected mice (6 h
p.i.) by collagenase digestion. DC were subsequently enriched over a
column using CD11c microbeads. Isolated DC were allowed to adhere
to poly-L-lysine coated cover slips for 15 min and then ﬁxed in 4%
paraformaldehyde for 30 min followed by washing with PBS. PFA was
quenched by washing with 50 mM ammonium chloride. Cells were
then stained with Alexa Fluor 647 conjugated anti-mouse CD8α
(BioLegend, San Diego, CA) and PE-conjugated CD11c (PharMingen,
San Diego, CA) and mounted in ProLong Gold antifade reagent with
DAPI (Invitrogen,Eugene,OR). Isotype matched antibodies were used
as a control for non-speciﬁc binding and mock-infected cells were
used to set exposure times for eGFP expression by infected cells. Cells
were visualized using a Nikon Eclipse TE300 ﬂuorescent microscope
using a 60×/0.70 objective. Images were collected using a Retiga EX
QImaging camera and analyzed with Adobe Photoshop software.
IL-12p40 production by DC
Splenocytes were cultured overnight in the presence of GolgiPlug in
RPMI 1640 medium (Invitrogen Life Technologies) supplemented
with 10% FCS (Sigma), HEPES, gentamicin sulfate (BioWhittaker), and
5×10−5 M 2-ME . 20 ng/ml rGM-CSF (Biosource International) was also
added to enhance survival of the DC population. Following culture, cells
were stained with anti-CD11c-PE and anti-CD8-PerCpCy5.5 antibodies.
150 R.D. Yammani et al. / Virology 378 (2008) 142–150Cells were then washed, ﬁxed, permeabilized and stained with anti-IL-
12p40-APC antibody. Samples were acquired on a FacsCalibur and data
analyzed with CellQuest software (both from BD, San Diego, CA).
OT-I activation assay
At 6 or 24 h p.i. DC were enriched from the spleen followed by
staining with CD11c and CD8-antibodies. DC subsets were sorted based
on CD8 expression. OT-I transgenic T cells were co-cultured with sorted
DC for 3 days at a ratio of 1:2.5 at 37 °C in a 96-well plate (4×104 T cells
and 1×105 DC). Following culture, cells were harvested and restimu-
latedwith 10−6MOva257–264 peptide for 5 h in the presence of GolgiPlug
(BD, San Diego, CA). Cells were then stained with anti-CD8-PerCpCy5.5
antibody, ﬁxed, permeabilized, and IFN production assessed by
intracellular staining with anti IFNγ-PE antibodies.
In vivo activation of OT-I cells
Splenocytes (105) isolated from OT-I mice were intravenously
administered to CD8-deﬁcient C57BL/6 mice at 6, 24, or 48 h post-
infectionwith VACV-NP-S-EGFP. Three days post-transfer, splenocytes
were harvested and Ova-speciﬁc responses determined by analysis of
IFNγ production using ICCS as described above. Timing of infections
were such that OT-I transfers were performed on the same day and
Ova257–264-speciﬁc responses from all conditionsmeasured in parallel.
Statistical analyses
All p values were calculated using the Student's t test unless
otherwise indicated.
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